Metabolic Syndrome in Obese Children-Clinical Prevalence and Risk Factors

Agnieszka Jankowska1, Michał Brzeziński1, Anna Romanowicz-Sołtyszewska2

  • 1Department of Paediatrics, Gastroenterology, Allergology and Paediatric Nutrition, Medical University of Gdańsk, 80-462 Gdańsk, Poland.

Insights

Identifying risk factors for metabolic syndrome (MetS) in obese children is crucial. Male sex, parental obesity, low birth weight, and skipping meals are key predictors, some of which are modifiable.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Childhood obesity is a growing global health concern.
  • Obese children are at increased risk of developing metabolic syndrome (MetS).
  • Identifying modifiable risk factors for MetS in children is essential for early intervention.

Purpose of the Study:

  • To identify predisposing factors for metabolic syndrome in obese children.
  • To focus on modifiable risk factors for MetS in this population.

Main Methods:

  • Study included 591 obese Caucasian children aged 10-12 years from Gdańsk, Poland.
  • Methods involved clinical examination, anthropometry, biometric impedance analysis, blood tests (OGTT, insulinemia), and lifestyle assessments (diet, physical activity).

Main Results:

  • Risk factors for MetS in obese children included male sex, parental obesity (especially paternal), and low birth weight.
  • Omitting breakfast or dinner were significant dietary risk factors.
  • Few risk factors for MetS were identified, highlighting the importance of these specific predictors.

Conclusions:

  • Predisposing factors for metabolic syndrome in obese children are identifiable.
  • Modifiable lifestyle factors, such as regular meal patterns, are crucial for reducing MetS risk.
  • Intervention targeting these factors can improve long-term health outcomes and quality of life in obese children.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
925
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.8K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
109
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
78
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.4K